Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Berteloot · SciRah

Researcher profile · Semantic Scholar

P. Berteloot

Share profile

P. Berteloot — researcher profile on SciRah

h-index: 30
Works: 203
Citations: 3,068

Most-cited papers

Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
F. Amant, M. Verheecke, I. Wlodarska, L. Dehaspe +16 more
2015JAMA Oncology208 citations
Semantic Scholar
Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
K. Michielsen, R. Dresen, R. Vanslembrouck, F. De Keyzer +7 more
2017European Journal of Cancer117 citations
Semantic Scholar
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
M. Colleoni, W. Luo, P. Karlsson, J. Chirgwin +248 more
2018The Lancet Oncology97 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
I. Vandenput, B. van Calster, An Capoen, K. Leunen +5 more
2009British Journal of Cancer93 citations Open access
Semantic Scholar
Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy.
E. Despierre, S. Lambrechts, K. Leunen, P. Berteloot +5 more
2013Gynecologic Oncology77 citations
Semantic Scholar
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.
Kim Haest, Anujith Kumar, B. van Calster, K. Leunen +15 more
2012Annals of Oncology67 citations Open access
Semantic Scholar
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors
T. van Cann, T. Loyson, A. Verbiest, P. Clement +16 more
2018Supportive Care in Cancer63 citations Open access
Semantic Scholar
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial
P. Neven, L. Jongen, A. Lintermans, K. Van Asten +21 more
2018Clinical Cancer Research56 citations Open access
Semantic Scholar
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers.
O. Brouckaert, A. Laenen, J. Vanderhaegen, H. Wildiers +13 more
2012Annals of Oncology54 citations Open access
Semantic Scholar
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.
H. Dauwen, B. van Calster, C. Deroose, K. D. de Beeck +6 more
2013Gynecologic Oncology53 citations
Semantic Scholar
Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab
Tine Loyson, T. van Cann, P. Schöffski, P. Clement +14 more
2018Acta Clinica Belgica52 citations
Semantic Scholar
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
G. Floris, F. Richard, A. Hamy, L. Jongen +14 more
2020Journal of the National Cancer Institute45 citations Open access
Semantic Scholar
Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in platinum-resistant ovarian cancer.
A. Vanderstichele, E. Van Nieuwenhuysen, Sileny N. Han, N. Concin +6 more
2019Journal of Clinical Oncology39 citations
Semantic Scholar
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial.
L. Loverix, I. Vergote, P. Busschaert, A. Vanderstichele +21 more
2023European Journal of Cancer32 citations
Semantic Scholar
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors
O. Brouckaert, S. Pintens, V. Belle, S. Van Huffel +17 more
2009Breast Cancer Research and Treatment25 citations
Semantic Scholar
Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy
L. Jongen, G. Floris, H. Wildiers, F. Claessens +9 more
2019Breast Cancer Research and Treatment24 citations
Semantic Scholar
Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6)
L. Loverix, I. Vergote, P. Busschaert, A. Vanderstichele +21 more
2022Gynecologic Oncology23 citations
Semantic Scholar
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer.
A. Vanderstichele, L. Loverix, P. Busschaert, E. Van Nieuwenhuysen +10 more
2022Gynecologic Oncology22 citations
Semantic Scholar
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
Elisa Van Raemdonck, G. Floris, P. Berteloot, A. Laenen +4 more
2020Breast Cancer Research and Treatment22 citations Open access
Semantic Scholar
Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group.
I. Vergote, P. Debruyne, F. Kridelka, P. Berteloot +12 more
2015Gynecologic Oncology22 citations
Semantic Scholar
The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium: A Collaborative Study
I. Vandenput, J. Trovik, I. Vergote, P. Moerman +5 more
2010International Journal of Gynecologic Cancer22 citations Open access
Semantic Scholar
Leuven Dose-Dense Paclitaxel/Carboplatin Regimen in Patients With Primary Advanced or Recurrent Endometrial Carcinoma
I. Vandenput, I. Vergote, K. Leunen, P. Berteloot +2 more
2009International Journal of Gynecologic Cancer22 citations Open access
Semantic Scholar
Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer.
Sofie Torfs, I. Cadron, F. Amant, K. Leunen +2 more
2012European Journal of Cancer21 citations
Semantic Scholar
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users
A. Dieudonné, D. Lambrechts, B. Claes, T. Vandorpe +15 more
2009Breast Cancer Research and Treatment15 citations
Semantic Scholar
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer
G. Hoste, K. Punie, H. Wildiers, Benoit Beuselinck +8 more
2018Breast Cancer Research and Treatment14 citations
Semantic Scholar
The "Leuven" paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study.
I. Cadron, L. Abdulkadir, E. Despierre, P. Berteloot +4 more
2013Gynecologic Oncology12 citations
Semantic Scholar
Cause of death for patients with breast cancer: discordance between death certificates and medical files, and impact on survival estimates
H. Izci, T. Tambuyzer, J. Vandeven, Jérôme Xicluna +13 more
2021Archives of Public Health11 citations Open access
Semantic Scholar
Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.
Sileny N. Han, F. Amant, K. Leunen, U. Devi +3 more
2012Gynecologic Oncology9 citations
Semantic Scholar
Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report and Review of the Literature
I. Dierickx, G. Jacomen, V. Schelfhout, P. Moerman +4 more
2010Gynecologic and Obstetric Investigation9 citations
Semantic Scholar
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?
K. Leunen, I. Cadron, T. van Gorp, F. Amant +4 more
2009International Journal of Gynecologic Cancer8 citations Open access
Semantic Scholar
Does the Stellate Ganglion Block Reduce Severe Hot Flushes and Sleep Disturbances in Breast Cancer Patients
Kim Haest, Anujith Kumar, K. Leunen, A. Smeets +14 more
20095 citations
Semantic Scholar
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort
S. Thijssen, H. Wildiers, K. Punie, B. Beuselinck +15 more
2021Journal of Cancer Research and Clinical Oncology4 citations Open access
Semantic Scholar
Prospective study evaluating the effect of impaired tamoxifen metabolisation on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting.
A. Lintermans, K. Van Asten, L. Jongen, C. Blomme +16 more
20164 citations
Semantic Scholar
Abstract P3-07-46: CYPTAM-BRUT 3: Endometrial thickness cannot be used as a marker for tamoxifen metabolization in postmenopausal breast cancer patients
A. Poppe, A. Dieudonné, A. Lintermans, A. Laenen +15 more
20163 citations
Semantic Scholar
Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers
I. Vergote, B. Lund, H. Havsteen, Z. Ujmajuridze +16 more
20163 citations Open access
Semantic Scholar
Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer.
P. Neven, L. Jongen, K. Van Asten, P. Berteloot +2 more
2015Annals of Oncology3 citations Open access
Semantic Scholar
Biology and prognosis by age of primary operable breast cancer.
O. Brouckaert, E. Camerlynck, V. Van Belle, S. Van Huffel +14 more
20093 citations
Semantic Scholar
569 The Leuven PARPi benefit test as improved approach for prediction of PARPi benefit in the PAOLA-1/ENGOTov25 trial
L. Loverix, I. Vergote, P. Busschaert, T. Venken +16 more
2024Oral Sessions2 citations Open access
Semantic Scholar
The prognostic role of the androgen receptor in patients with triple-negative early breast cancers and primary surgery.
L. Jongen, G. Floris, H. Wildiers, F. Claessens +9 more
2019Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Abstract P6-07-29: Independent prognostic value of age depends on breast cancer subtype
O. Brouckaert, R. Salihi, A. Laenen, J. Vanderhaegen +14 more
20122 citations
Semantic Scholar
Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole
B. van Calster, J. Van Ginderachter, J. Vlasselaer, G. van de Putte +11 more
2010Menopause2 citations
Semantic Scholar
2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer
S. Dumont, V. Vandecaveye, R. Dresen, E. Van Nieuwenhuysen +6 more
2022Ovarian cancer1 citations Open access
Semantic Scholar
817P Response to olaparib monotherapy in relapsed ovarian cancer by HRR gene mutational status and HRD scarring analysis: Results from the randomized phase II CLIO trial
A. Vanderstichele, Liselore Loverix, C. de Vogelaere, L. Heyrman +11 more
20201 citations Open access
Semantic Scholar
Abstract P5-09-05: Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations
G. Hoste, P. D'hoore, E. Legius, G. Van Buggenhout +12 more
2019Poster Session Abstracts1 citations
Semantic Scholar
The prognostic and predictive role of the androgen receptor in TNBC treated with neo-adjuvant chemotherapy.
L. Jongen, G. Floris, A. Laenen, Jan Ardui +5 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Abstract P6-09-11: Independent prognostic value of age depends on breast cancer subtype
A. Poppe, O. Brouckaert, A. Laenen, A. Soubry +14 more
20161 citations
Semantic Scholar
Circulating tumor cell number predicts time to progression (TTP) in patients with heavily pretreated gynecological cancers treated with selinexor (SEL)
M. Crochiere, I. Vergote, B. Lund, H. Havsteen +16 more
20161 citations Open access
Semantic Scholar
Adverse events with everolimus in BOLERO-2.
P. Neven, A. Poppe, P. Berteloot, P. Wolter +1 more
20141 citations Open access
Semantic Scholar
Abstract PS1-01-07: Tamoxifen use increases endometrial cancer risk in premenopausal breast cancer patients
Z. Molinari, N. Van Damme, J. Verbeeck, A. Laenen +18 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Abstract PO3-05-05: The effect of histological breast cancer subtype on progression free survival in patients with CDK4/6 inhibitors
C. Bauters, K. Van Baelen, H. Wildiers, G. Floris +13 more
2024Cancer Research0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Neven×31
Invite
P. Neven — researcher profile on SciRah
I. Vergote×24
Invite
I. Vergote — researcher profile on SciRah
H. Wildiers×18
Invite
H. Wildiers — researcher profile on SciRah
F. Amant×16
Invite
F. Amant — researcher profile on SciRah

×16

Invite

K. Leunen — researcher profile on SciRah

Invite

A. Smeets — researcher profile on SciRah

E. Van Nieuwenhuysen×14

Invite

E. Van Nieuwenhuysen — researcher profile on SciRah

Invite

I. Vergote — researcher profile on SciRah

Invite

A. Laenen — researcher profile on SciRah

Invite

C. Weltens — researcher profile on SciRah

Invite

P. Neven — researcher profile on SciRah

Invite

K. Punie — researcher profile on SciRah